Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Mirum Pharmaceuticals, Inc. (MIRM) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $16.60 Metrics
OS: 38.3 M -224 % ROE
Market cap: $636 M -255 % ROIC
Net cash: $24.3 M $0.64 per share
EV: $611 M

 
TTM Valuation
EBITDA
EBIT ($118) M
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
Revenues77.119.10.00.0
            Revenue growth302.7%   
Cost of goods sold0.00.00.00.0
Gross profit77.119.10.00.0
            Gross margin100.0%100.0%  
Selling, general and administrative89.1192.6104.3 
Research and development 131.481.643.0
General and administrative   11.8
EBIT-131.2-173.4-104.3-54.7
            EBIT margin-170.3%-906.1%  
Pre-tax income-142.1-84.0-103.3-52.5
Income taxes-6.40.00.00.0
            Tax rate4.5%   
Net income-135.7-84.0-103.3-52.6
            Net margin-176.0%-438.9%  
 
Diluted EPS($3.99)($2.77)($4.09)($4.58)
Shares outstanding (diluted)34.030.325.311.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy